WTX-116

N/A

Report date: 2024/12/20 17:07:03

Base Information

Drug NameWTX-116
Drug Alias Namepro-uPA-EryWTX-116
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWestlake Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesWestlake Therapeutics
Inactive CompaniesN/A
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A